Back to results
US 12,440,445 B2Granted
Fusogenic compounds for delivery of biologically active molecules
AssigneeNitto Denko Corporation
InventorsKwok Yin Tsang, Bharat Majeti, John Gaudette, Roger Adami, Hao Bai, Wenbin Ying
Life of this patent
Estimating the term…
Abstract
Fusogenic compounds, and compositions and methods of use thereof. The fusogenic compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, compounds, compositions and methods are to provide nanoparticles to incorporate or encapsulate active agents, to deliver and distribute the active agents to cells, tissues, organs, and subjects.
Claims11
A fusogenic compound having Formula VII:
- wherein each amphiphile has a structure represented by Formula VIII:
- wherein R1 and R2 are:
- R1 is CH2(CH2)nO(C═O)R4, CH2(CH2)nNH(C═O)R4, CH2(CH2)n(C═O)OR4, or CH2(CH2)n(C═O)NHR4;
- R2 or CH2(CH2)mO(C═O)R5, CH2(CH2)mNH(C═O)R5, CH2(CH2)m(C═O)OR5, or CH2(CH2)m(C═O)NHR5;
- wherein:
- n and m are each independently from 1 to 2;
- R4 and R5 are independently for each occurrence a C(12-20) alkyl group or a C(12-20) alkenyl group;
- wherein each AAa is independently an amino acid of the following structure, and any stereoisomer thereof:
- wherein the linker has a structure:
- wherein Q1 is selected from the group consisting of branched or unbranched C(2-8)alkandiyl, branched or unbranched C(2-8)alkenediyl, branched or unbranched C(2-8)alkynediyl,
- wherein Q2 is
- wherein Q3 is
- wherein X is selected from the group consisting of —O—, —S—, and —NH—;
- n and p are independently for each occurrence 1 to 3;
- m is independently 1 to 10;
- and
- r and s are independently for each occurrence 1 to 5.
14 more elements
Dependencies are inferred from the claim text.